Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRM1 known ✓ | P35372 | 1/20 | 0.52 |
| ▸ | S1PR2 known ✓ | O95136 | 5/20 | 0.50 |
| ▸ | S1PR1 known ✓ | P21453 | 5/20 | 0.50 |
| ▸ | S1PR3 known ✓ | Q99500 | 5/20 | 0.50 |
| ▸ | S1PR4 known ✓ | O95977 | 4/20 | 0.50 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.56 |
| ▸ | PLA2G2A | P14555 | 1/20 | 0.56 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.48 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.45 |
| ▸ | GMNN | O75496 | 1/20 | 0.45 |
| ▸ | LMNA | P02545 | 1/20 | 0.45 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | THPO | P40225 | 1/20 | 0.45 |
| ▸ | MTOR | P42345 | 1/20 | 0.45 |
| ▸ | BLM | P54132 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.45 |
| ▸ | TP53 | P04637 | 1/20 | 0.45 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.45 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.45 |
| ▸ | MAPT | P10636 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL27813034 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL1397744 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL26115524 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL11832911 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL10417683 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL27231791 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL28443603 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL10531869 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL11783993 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 | |
| Hydrochloric Acid SCHEMBL27755493 | 1.00 | PLA2G1B (0.56) | PLA2G1BPLA2G2AOPRM1S1PR2S1PR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 43 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2370066-B1 | METHOD FOR MANUFACTURING CAPSULE SERIES, AND RELATED CAPSULE SERIES | CAPSUM (FR) | 2016-03-30 | — | — | EP | claimed |
| US-9277759-B2 | Method for manufacturing capsule series, and related capsule series | CAPSUM (FR) | 2016-03-08 | — | — | US | claimed |
| CN-102585109-B | Styrene-acrylic emulsion and preparation method thereof | GUANGZHOU STARTEC SCIENCE & TECHNOLOGY CO LTD | 2013-12-18 | — | — | CN | claimed |
| US-20120003285-A1 | METHOD FOR MANUFACTURING CAPSULE SERIES, AND RELATED CAPSULE SERIES | CAPSUM (FR) | 2012-01-05 | — | — | US | claimed |
| US-20250386822-A1 | Microcapsules controlling the diffusion of an active organic compound | KAPSERA (FR) | 2025-12-25 | — | — | US | disclosed |
| WO-2025125229-A1 | DEVICE SUITABLE FOR PACKAGING A HETEROGENEOUS MIXTURE AND FOR DISPENSING SAME IN THE FORM OF A SPRAY OF FLUID COMPOSITION | CAPSUM (FR) | 2025-06-19 | — | — | WO | disclosed |
| EP-4547385-A1 | CAPSULE DRYING METHOD | Kapsera (FR) | 2025-05-07 | — | — | EP | disclosed |
| EP-4547019-A1 | MICROCAPSULES COMPRISING A UV FILTER | Kapsera (FR) | 2025-05-07 | — | — | EP | disclosed |
| EP-4547020-A1 | MICROCAPSULES CONTROLLING THE DIFFUSION OF AN ACTIVE ORGANIC COMPOUND | Kapsera (FR) | 2025-05-07 | — | — | EP | disclosed |
| CN-119768053-A | Microcapsules containing ultraviolet screening agent | 卡普塞拉股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119768054-A | Microcapsules capable of controlling diffusion of active organic compounds | 卡普塞拉股份有限公司 | 2025-04-04 | — | — | CN | disclosed |
| CN-119744195-A | Capsule drying method | 卡普塞拉股份有限公司 | 2025-04-01 | — | — | CN | disclosed |
| US-20120003285-A1 | METHOD FOR MANUFACTURING CAPSULE SERIES, AND RELATED CAPSULE SERIES | CAPSUM (FR) | 2012-01-05 | — | — | US | disclosed |
| US-7071270-B2 | Method for obtaining polybutadiene-based aqueous dispersions | ARKEMA (FR) | 2006-07-04 | — | — | US | disclosed |
| WO-2004067470-A1 | COMPOSITION COMPRINSING A HYDRAULIC BINDER AND A LATEX HAVING A SULFONATE, SULFONIC OR SULFOBETAINE FUNCTIONAL GROUP | RHODIA CHIMIE (FR) | 2004-08-12 | — | — | WO | disclosed |
| US-20040106727-A1 | Method for obtaining polybutadiene based aqueous dispersions | ARKEMA FRANCE (FR) | 2004-06-03 | — | — | US | disclosed |
| EP-0598836-A1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL. | ALLIED SIGNAL INC (US) | 1994-06-01 | — | — | EP | disclosed |
| US-5194539-A | Of ethylenically unsaturated monomers where the aqueous dispersion is free from odor causing xanthogen disulfide | RHONE-POULENC CHIMIE (FR) | 1993-03-16 | — | — | US | disclosed |
| WO-1993004117-A1 | MELT PROCESS FORMATION OF POLYMER NANOCOMPOSITE OF EXFOLIATED LAYERED MATERIAL | ALLIED-SIGNAL INC. (US) | 1993-03-04 | — | — | WO | disclosed |
| EP-0329389-A2 | Polyurethane base lens and its preparation method | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1989-08-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250386822-A1 | Microcapsules controlling the diffusion of an active organic compound | LAGE3, TFEB, BUB3 | OPRM1 1090/4885S1PR2 3355/4885S1PR1 3175/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.